🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for Refractory Rheumatoid Arthritis (RA)

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases NCT06978647Phase 11 site📍 Beijing China Immunotech (Beijing) Biotechnology Co., Ltd. · Tests: YTS109 cell Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases NCT07085676Phase 11 site📍 Jerusalem Polina Stepensky · Tests: HBI0101 CART The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection NCT07001956EARLY Phase 11 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: UTAA91 injection AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. NCT06991114Phase 252 sites📍 Tuscaloosa📍 Phoenix📍 Tucson Artiva Biotherapeutics, Inc. · Tests: Allogeneic NK Cells A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases NCT07115745Phase 128 sites📍 Boston📍 Durham📍 Camperdown Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · Tests: BMS-986515, Fludarabine, Cyclophosphamide, Tocilizumab Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis NCT07721142Phase 41 site📍 Shanghai Shanghai Guanghua Hospital of Integrated Traditional Chines… · Tests: Kunxian Capsule, Kunxian Capsule Placebo An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis NCT06946199Phase 11 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: Cizutamig, Cizutamig A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis NCT06994143Phase 14 sites📍 Erlangen📍 Heidelberg📍 Rome Cullinan Therapeutics Inc. · Tests: CLN-978 Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis NCT07491016n/a1 site📍 Hangzhou Zhejiang Provincial People's Hospital Safety Study of CC312 in Autoimmune Disease Patients NCT06888960EARLY Phase 11 site📍 Tianjin CytoCares Inc · Tests: CC312 A Phase 1 Study of ADI-001 in Rheumatoid Arthritis NCT07100873Phase 11 site📍 Shanghai Adicet Therapeutics · Tests: ADI-001, Fludarabine, Cyclophosphamide A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 NCT07403188n/a1 site📍 Denver Kyverna Therapeutics · Tests: KYV-101
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy